Similarly, while the ROCK1/2 dual inhibitor, H-1152, potently inhibited the TEAD reporter in both tumor lines, KD025, a selective ROCK2 inhibitor48, failed to do so even at much higher concentrations (Fig. 4c, d). Here, ROCK2 is linked to neoplasm.